Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
- PMID: 17166244
- DOI: 10.1111/j.1538-7836.2007.02369.x
Microparticle-associated tissue factor activity: a link between cancer and thrombosis?
Abstract
Background: Cancer, in particular mucinous adenocarcinoma, is associated with venous thromboembolism (VTE). Tissue factor (TF), initiator of coagulation, plays a central role in the paradigm that clotting and tumor growth form a vicious circle, in which hypercoagulability facilitates the aggressive biology of cancer and vice versa. Expression of TF in tumors is associated with poor differentiation and poor prognosis.
Patient/methods: We investigated the association between clinically manifest VTE and procoagulant properties of circulating microparticles (MP) isolated from blood of unselected pancreatic and breast adenocarcinoma patients' consecutive subjects, who presented with ultrasound or CT-scan confirmed VTE, and healthy subjects.
Results: Patients with disseminated breast and pancreatic cancer had significantly increased levels of MP-associated TF activity compared with healthy controls, subjects with idiopathic acute VTE and non-metastatic cancer patients. Patients with both high MP-associated TF-activity and MP-associated epithelial mucin (MUC1) had a lower survival rate at 3-9 months follow-up than those with low TF-activity and no MUC1 expression: the likelihood of survival was 0.42 (95% CI: 0.19- 0.94) for an individual with these two predictor variables present, after adjustment for other factors (age cohort, type of cancer, VTE) in the Cox proportional hazards model.
Conclusions: Our results suggest an important role for MP-associated TF and MUC1 in the pathogenesis of thrombosis in disseminated mucinous adenocarcinoma patients. Future studies should reveal the mechanism underlying the observed associations.
Similar articles
-
Circulating microparticle tissue factor, thromboembolism and survival in pancreaticobiliary cancers.Thromb Res. 2013 Aug;132(2):180-4. doi: 10.1016/j.thromres.2013.06.026. Epub 2013 Jul 13. Thromb Res. 2013. PMID: 23856554
-
Microparticle-associated tissue factor activity in patients with pancreatic cancer: correlation with clinicopathological features.Eur J Clin Invest. 2013 Mar;43(3):277-85. doi: 10.1111/eci.12042. Epub 2013 Feb 9. Eur J Clin Invest. 2013. PMID: 23398637
-
Tissue factor-bearing microparticles and CA19.9: two players in pancreatic cancer-associated thrombosis?Br J Cancer. 2016 Jul 26;115(3):332-8. doi: 10.1038/bjc.2016.170. Epub 2016 Jul 12. Br J Cancer. 2016. PMID: 27404454 Free PMC article.
-
Tissue factor positive microparticles as a biomarker for increased risk of breast cancer-associated thrombosis: a mini review.Curr Opin Hematol. 2023 Sep 1;30(5):180-185. doi: 10.1097/MOH.0000000000000774. Curr Opin Hematol. 2023. PMID: 37522480 Review.
-
Tumor-derived tissue factor-positive microparticles and venous thrombosis in cancer patients.Blood. 2013 Sep 12;122(11):1873-80. doi: 10.1182/blood-2013-04-460139. Epub 2013 Jun 24. Blood. 2013. PMID: 23798713 Free PMC article. Review.
Cited by
-
Platelet-Derived Procoagulant Microparticles as Blood-based Biomarker of Breast Cancer.Asian Pac J Cancer Prev. 2021 May 1;22(5):1573-1579. doi: 10.31557/APJCP.2021.22.5.1573. Asian Pac J Cancer Prev. 2021. PMID: 34048188 Free PMC article.
-
Prognostic significance of tissue factor in patients with pancreatic cancer: a systematic review protocol.BMJ Open. 2020 Sep 14;10(9):e037431. doi: 10.1136/bmjopen-2020-037431. BMJ Open. 2020. PMID: 32928856 Free PMC article.
-
Procoagulant Activity of Red Blood Cell-Derived Microvesicles during Red Cell Storage.Transfus Med Hemother. 2019 Aug;46(4):224-230. doi: 10.1159/000494367. Epub 2018 Nov 13. Transfus Med Hemother. 2019. PMID: 31700504 Free PMC article.
-
Predictors of Venous Thromboembolism After Nonemergent Craniotomy: A Nationwide Readmission Database Analysis.World Neurosurg. 2019 Feb;122:e1102-e1110. doi: 10.1016/j.wneu.2018.10.237. Epub 2018 Nov 20. World Neurosurg. 2019. PMID: 30465948 Free PMC article.
-
Coagulation in Brain Tumors: Biological Basis and Clinical Implications.Front Neurol. 2019 Mar 18;10:181. doi: 10.3389/fneur.2019.00181. eCollection 2019. Front Neurol. 2019. PMID: 30949114 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous